Eribulin

Eribulin
Product Description

Breast cancer liposarcoma
Status: under development

Zenji Research Laboratories

  • CN
  • 2021
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Academic/Research
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    253128-41-5

Zenji Research Laboratories

  • CN
  • 2021
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Academic/Research
Manufacturer/Innovator

More Products from Zenji Research Laboratories (2)